These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7437816)

  • 21. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Woodruff TG
    Med J Aust; 2004 Oct; 181(8):458. PubMed ID: 15487968
    [No Abstract]   [Full Text] [Related]  

  • 22. The James B. Herrick Award Lecture. 2003. Clinical research: whose agenda is it?
    Cohn JN
    Circulation; 2004 May; 109(19):2256-62. PubMed ID: 15148282
    [No Abstract]   [Full Text] [Related]  

  • 23. Cancer drugs offer hope, but at huge expense.
    Berenson A
    N Y Times Web; 2005 Jul; ():A1, C3. PubMed ID: 16075470
    [No Abstract]   [Full Text] [Related]  

  • 24. Erectile dysfunction and the internet: drug company manipulation of public and professional opinion.
    Read J; Mati E
    J Sex Marital Ther; 2013; 39(6):541-59. PubMed ID: 23672238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Masters S
    Med J Aust; 2004 Oct; 181(8):459; discussion 459. PubMed ID: 15612086
    [No Abstract]   [Full Text] [Related]  

  • 26. The drug culture.
    Taylor MA
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Oct; 13(4):231-2. PubMed ID: 11186157
    [No Abstract]   [Full Text] [Related]  

  • 27. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Graudins LV
    Med J Aust; 2004 Oct; 181(8):458-9. PubMed ID: 15612085
    [No Abstract]   [Full Text] [Related]  

  • 28. In article, doctors back ban on drug companies' gifts; concerns cited on quality of patient care.
    Harris G
    N Y Times Web; 2006 Jan; ():A14. PubMed ID: 16450472
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug prices,public opinion, legal measures].
    TEUNISSEN HP
    Pharm Weekbl; 1962 May; 97():425-32. PubMed ID: 13920455
    [No Abstract]   [Full Text] [Related]  

  • 30. PUBLIC attitudes toward prescription costs and the drug industry.
    SD J Med Pharm; 1960 Jul; 13():398-400 passim. PubMed ID: 13858297
    [No Abstract]   [Full Text] [Related]  

  • 31. Doctors object as drug makers learn who's prescribing what.
    Saul S
    N Y Times Web; 2006 May; ():A1, C4. PubMed ID: 16718959
    [No Abstract]   [Full Text] [Related]  

  • 32. Most Australians believe that drug company payments influence doctors' decisions.
    Moynihan R
    BMJ; 2012 Feb; 344():e1076. PubMed ID: 22331321
    [No Abstract]   [Full Text] [Related]  

  • 33. Ethical issues in continuing professional development.
    Abratt RP
    S Afr Med J; 2002 Feb; 92(2):97-8. PubMed ID: 11894659
    [No Abstract]   [Full Text] [Related]  

  • 34. Physicians, the industry and population health.
    Gérvas J; Mansfield PR
    J Epidemiol Community Health; 2009 Oct; 63(10):773-4. PubMed ID: 19749125
    [No Abstract]   [Full Text] [Related]  

  • 35. Briggs: the image and the reality.
    Nurs Times; 1972 Nov; 68(45):Suppl:1-4. PubMed ID: 5087214
    [No Abstract]   [Full Text] [Related]  

  • 36. Optometry's urban image.
    Beasley JC
    J Am Optom Assoc; 1970 Jun; 41(6):537-9. PubMed ID: 5427575
    [No Abstract]   [Full Text] [Related]  

  • 37. Building legitimacy by criticising the pharmaceutical industry: a qualitative study among prescribers and local opinion leaders.
    Pittet AL; Saraga M; Stiefel F
    Swiss Med Wkly; 2015; 145():w14240. PubMed ID: 26661626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physician preferences and attitudes regarding industry support of CME programs.
    Mueller PS; Hook CC; Litin SC
    Am J Med; 2007 Mar; 120(3):281-5. PubMed ID: 17349454
    [No Abstract]   [Full Text] [Related]  

  • 39. Restoring trust to managed care, Part 3: A focus on public stakeholders.
    Kirkman-Liff B
    Am J Manag Care; 2003 Apr; 9(4):322-6. PubMed ID: 12703676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical ethics, research and the pharmaceutical industry.
    Abud-Mendoza C
    Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.